Desvenlafaxine, a serotonin-norepinephrine uptake inhibitor for major depressive disorder, neuropathic pain and the vasomotor symptoms associated with menopause

scientific article published on January 2009

Desvenlafaxine, a serotonin-norepinephrine uptake inhibitor for major depressive disorder, neuropathic pain and the vasomotor symptoms associated with menopause is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID19127490

P2093author name stringAshwin A Patkar
Changsu Han
Chi-Un Pae
Prakash S Masand
David M Marks
Min-Hyeon Park
P433issue1
P921main subjectmajor depressive disorderQ42844
norepinephrineQ186242
neuropathic painQ2798704
P304page(s)75-90
P577publication date2009-01-01
P1433published inCurrent Opinion in Investigational DrugsQ15724634
P1476titleDesvenlafaxine, a serotonin-norepinephrine uptake inhibitor for major depressive disorder, neuropathic pain and the vasomotor symptoms associated with menopause
P478volume10

Reverse relations

cites work (P2860)
Q38416566A double-blind, placebo-controlled, parallel-group pilot study of milnacipran for chronic radicular pain (sciatica) associated with lumbosacral disc disease
Q33896539Hybrid polymeric matrices for oral modified release of Desvenlafaxine succinate tablets
Q57283606Is calcitonin gene-related peptide a modulator of menopausal vasomotor symptoms?
Q42148416Open-label milnacipran for patients with persistent knee pain 1 year or longer after total knee arthroplasty: a pilot study
Q26797416Optimizing the Use of Aripiprazole Augmentation in the Treatment of Major Depressive Disorder: From Clinical Trials to Clinical Practice
Q38248064The narcotic bowel syndrome: a recent update

Search more.